Xconomy National

Archives

by in
Entry Author Date Location
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug Luke Timmerman 02/01/10 Seattle
AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study Luke Timmerman 12/22/09 Seattle
AVI Biopharma Settles Into New Digs, Scopes Out Seattle Biotech Talent Pool Luke Timmerman 09/29/09 Seattle
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News Luke Timmerman 09/03/09 Seattle
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain Luke Timmerman 09/01/09 Seattle
AVI Wins Part of $2.5M Contract Luke Timmerman 05/06/09 Seattle
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why Luke Timmerman 10/14/08 Boston
Genzyme, PTC Therapeutics Form Collaboration on Drug For Genetic Diseases Luke Timmerman 07/17/08 Boston
Page 1 of 1
    

Xconomy Events

Xconomy Forum: Reinventing Biotech’s Business Model

Register or Learn More

Xconomy’s Most Popular

  1. The 10 Social News Apps You Need to Try
  2. 7 Lessons from TechStars’ David Cohen on Building a Startup Culture
  3. Q4 Venture Deals, Dollars Stayed Strong, Making 2011 Best in a Decade
  4. With TV App, Dijit Hopes to Ride Out the Coming Apple Revolution in TV
  5. 10 Apps & Sites That Bring Back the Joy of Reading

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.